Pharmacie Samanci Sevim SRL
Pharmacie Samanci Sevim reported total assets of 69,293 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Aug 2026).
The score of Pharmacie Samanci Sevim shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -81 % Total assets -43 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmacie Samanci Sevim's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Aug 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 10 Sep 2024
- Year ended 31 Dec 2022filed on 06 Aug 2023
- Year ended 31 Dec 2021filed on 16 Sep 2022
Pharmacie Samanci Sevim's financial analysis
- Solvency31.2%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmacie Samanci Sevim
Pharmacie Samanci Sevim's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0766.690.869
- VAT number
- BE0766690869
- Peppol
- Registered · 0208:0766690869 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Apr 2021
- Registered office
- 6210 Les Bons Villers
- Latest accounts
- 2025 · filed on 30 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmacie Samanci Sevim (SRL) has been based in Les Bons Villers since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 25,043 € and equity of 21,601 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmacie Samanci Sevim
Companies in the same business, of comparable size and area, outside its group.
- Apr. Marjan Van Cleemput Retail sale of pharmaceutical products Aalter · balance sheet 68,105 €
- Beukeleirs Holding Retail sale of pharmaceutical products Vielsalm · balance sheet 66,647 €
- Carva Care Retail sale of pharmaceutical products Heist-op-den-Berg · balance sheet 72,190 €
- LouksPharma Retail sale of pharmaceutical products Fernelmont · balance sheet 72,654 €
- Apr. ZEYREK Retail sale of pharmaceutical products Leuven · balance sheet 72,982 €
- Apotheker Van De Weghe Karen Retail sale of pharmaceutical products Sint-Martens-Latem · balance sheet 73,167 €
- TV Retail sale of pharmaceutical products Haacht · balance sheet 65,446 €
- Arkophar Retail sale of pharmaceutical products Zutendaal · balance sheet 73,718 €
Frequently asked questions about Pharmacie Samanci Sevim
What is the revenue of Pharmacie Samanci Sevim?
Pharmacie Samanci Sevim files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmacie Samanci Sevim?
In Belgium, the VAT number is the company number prefixed with BE: BE0766690869 for Pharmacie Samanci Sevim, if the company is VAT-registered. Its company number (CBE) is 0766.690.869.
Where is the registered office of Pharmacie Samanci Sevim?
According to the CBE register, the registered office of Pharmacie Samanci Sevim is in 6210 Les Bons Villers.
What is the equity of Pharmacie Samanci Sevim?
At the close of the 2025 financial year, the equity of Pharmacie Samanci Sevim amounts to 21,601 €, a solvency of 31.2% of total assets.
Who manages Pharmacie Samanci Sevim?
The register lists 1 active mandates at Pharmacie Samanci Sevim. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmacie Samanci Sevim
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →